A vaccine for the Covid-19 illness caused by the coronavirus is on the verge of being developed, a team of scientists has said.
Researchers, led by Mucosal Infection and Immunity head Dr Robin Shattock, told the Daily Express they have successfully trialled the vaccine in mice and are hopeful it could be ready for human trials by June.
Senior researcher Dr Paul McKay, of Imperial College London, told the paper: “I’ve got results from a month after I injected (the mice) and the vaccine works really, really well.”
Into people by June
The team is working with scientists in Paris to determine the vaccine’s effectiveness in monkeys.
Dr McKay said they have applied for further funding from the Medical Research Council to conduct human clinical trials.
“If we get the funding for the human clinical trials, we will put it into people by June,” he said.
“If British scientists here develop a vaccine it would be great if the Government supported it.”
Should the human trials be successful, the team is hopeful the vaccine will be available for patients in a year.
Related: UK will leave EU at the end of the year “regardless of outbreak”
Since you are here
Since you are here, we wanted to ask for your help.
Journalism in Britain is under threat. The government is becoming increasingly authoritarian and our media is run by a handful of billionaires, most of whom reside overseas and all of them have strong political allegiances and financial motivations.
Our mission is to hold the powerful to account. It is vital that free media is allowed to exist to expose hypocrisy, corruption, wrongdoing and abuse of power. But we can't do it without you.
If you can afford to contribute a small donation to the site it will help us to continue our work in the best interests of the public. We only ask you to donate what you can afford, with an option to cancel your subscription at any point.
To donate or subscribe to The London Economic, click here.
The TLE shop is also now open, with all profits going to supporting our work.
The shop can be found here.
You can also SUBSCRIBE TO OUR NEWSLETTER .
